UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Researchers offer insights into immunotherapy for treating Covid-19
A global research team has stressed that immune therapy, such as convalesce...
by Lee Han-soo
|
2020-05-12 11:03
라인
HanAll’s profit increases despite sales drop in Q1
HanAll Biopharma said that it has posted 22.1 billion won ($18.1 million) i...
by Lee Han-soo
|
2020-05-11 18:37
라인
AbbVie finishes takeover of Allergan
AbbVie announced that it has completed the acquisition of Allergan followin...
by Lee Han-soo
|
2020-05-11 17:15
라인
Boryung gets local sales rights for Eli Lilly’s cancer drug
Boryung Pharmaceutical said it has obtained the right to market Eli Lilly’s...
by Lee Han-soo
|
2020-05-11 17:15
라인
ST Pharm's P1 trial of AIDS treatment gets French regulator’s nod
ST Pharm said that France's drug regulatory agency, ANSM, has approved ...
by Lee Han-soo
|
2020-05-11 14:38
라인
K-quarantine goods help boost health industry’s April export
Korean healthcare industry’s exports increased significantly in April thank...
by Lee Han-soo
|
2020-05-11 11:49
라인
Korea sees relapse in confirmed cases after group infection in Itaewon
Korea saw its biggest single-day spike in confirmed Covid-19 cases since Ap...
by Lee Han-soo
|
2020-05-10 13:32
라인
Vatech’s AI dental software gets FDA certification
Vatech said that the U.S. Food and Administration has certified EzOrtho, ar...
by Lee Han-soo
|
2020-05-08 17:23
라인
Bridge Biotherapeutics scores regulatory nod for trial of NSCLC treatment
Bridge Biotherapeutics said that the Ministry of Food and Drug Safety has g...
by Lee Han-soo
|
2020-05-08 15:45
라인
GC joins global plasma alliance to develop Covid-19 therapy
GC said that it has joined the CoVIg-19 Plasma Alliance, composed of global...
by Lee Han-soo
|
2020-05-08 15:45
라인
Hanmi applies for market launch of Korea’s 1st new bio-drug
Hanmi Pharmaceutical submitted a new drug approval application for Rolontis...
by Lee Han-soo
|
2020-05-08 15:45
라인
Arrest warrant sought for Sillajen’s CEO
Prosecutors have requested a court to issue an arrest warrant for Sillajen ...
by Lee Han-soo
|
2020-05-08 15:43
라인
'Neural stem cell effective in treating Huntington's disease'
Researchers at CHA University School of Medicine have discovered in a precl...
by Lee Han-soo
|
2020-05-07 16:45
라인
Celltrion Healthcare launches Remsima SC in Netherlands
Celltrion Healthcare said that it launched Remsima SC, an autoimmune biosim...
by Lee Han-soo
|
2020-05-07 14:53
라인
AMC to use stem cell therapy in treating graft-versus-host disease
Korean researchers have found a signal transduction system that modulates t...
by Lee Han-soo
|
2020-05-07 11:55
라인
ISU Abxis’ US partner gets EU patent for hemophilia B drug
ISU Abxis said that the company’s U.S. partner Catalyst Biosciences has acq...
by Lee Han-soo
|
2020-05-07 11:22
라인
Regulator OKs Rayence's AI-based X-ray
Rayence said that the Ministry of Food and Drug Safety has approved Xmaru P...
by Lee Han-soo
|
2020-05-06 17:23
라인
State research organ licenses out Covid-19 vaccine candidate
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said it ...
by Lee Han-soo
|
2020-05-06 16:23
라인
SNUH to use digital tech to treat obesity
A research team at Seoul National University Hospital has developed a digit...
by Lee Han-soo
|
2020-05-06 15:07
라인
Daewoong confirms 99% cure rate in trial of gastric acid blocker
Daewoong Pharmaceutical said that it has confirmed that fexuprazan, its gas...
by Lee Han-soo
|
2020-05-06 13:54
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top